CXCR4 and osteosarcoma: Forced re-expression of CXCR4 in the 143B FOXC2 knockdown cells restored their invasive capabilities in vitro (Figure 7C) and in vivo (Table S2), indicating that CXCR4 is a downstream target and a functional mediator of FOXC2 signaling in osteosarcoma.